Tesaro (Tesaro) Change In Inventory : $-78.8 Mil (TTM As of Sep. 2018)

View and export this data going back to 2012. Start your Free Trial

What is Tesaro Change In Inventory?

Tesaro's change in inventory for the quarter that ended in Sep. 2018 was $-20.3 Mil. It means Tesaro's inventory increased by $20.3 Mil from Jun. 2018 to Sep. 2018 .

Tesaro's change in inventory for the fiscal year that ended in Dec. 2017 was $-60.0 Mil. It means Tesaro's inventory increased by $60.0 Mil from Dec. 2016 to Dec. 2017 .

Tesaro's Total Inventories for the quarter that ended in Sep. 2018 was $108.8 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Tesaro's Days Inventory for the quarter that ended in Sep. 2018 was 598.74.

Inventory Turnover measures how fast the company turns over its inventory within a year. Tesaro's Inventory Turnover for the quarter that ended in Sep. 2018 was 0.15.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Tesaro's Inventory-to-Revenue for the quarter that ended in Sep. 2018 was 1.52.

Tesaro Change In Inventory Historical Data

The historical data trend for Tesaro's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tesaro Change In Inventory Chart

Tesaro Annual Data

Trend

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Change In Inventory

Get a 7-Day Free Trial

-1.11

-13.59

-59.97

Tesaro Quarterly Data
	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18
Change In Inventory	Get a 7-Day Free Trial															-28.87	-24.14	-16.20	-18.11	-20.33

Tesaro Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Sep. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $-78.8 Mil.

Tesaro (NAS:TSRO) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Tesaro's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	98.114	/	14.953	*	365 / 4
	=	598.74

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Tesaro's Inventory Turnover for the quarter that ended in Sep. 2018 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	14.953	/	98.114
	=	0.15

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Tesaro's Inventory to Revenue for the quarter that ended in Sep. 2018 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	98.114	/	64.399
	=	1.52

Tesaro Change In Inventory Related Terms

Thank you for viewing the detailed overview of Tesaro's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Tesaro (Tesaro) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tesaro Inc (NAS:TSRO) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.tesarobio.com

Tesaro is an oncology-focused biopharmaceutical company with a focus on developing treatments for cancer. Upon successful development and regulatory approval of any of its product candidates, the company intends to pursue commercialization in key product markets, including North America, Europe, and China. Tesaro is currently focused on commercializing products directly in North America, and directly or in partnership with established companies in Europe and China. The company's strategy is to identify, acquire, and develop promising drug candidates, and to commercialize cancer therapeutics that are potentially safer and more effective than existing treatments.

Executives

Mary Lynne Hedley	director, officer: President & COO	C/O TESARO, INC., 1000 WINTER ST., STE 3300, WALTHAM MA 02451
Kavita Patel	director	C/O TESARO, INC., 1000 WINTER STREET, SUITE 3300, WALTHAM MA 02451
Huber Martin H. Jr.	officer: SVP & Chief Medical Officer	C/O TESARO, INC., 1000 WINTER STREET, SUITE 3300, WALTHAM MA 02451
Moulder Leon O Jr	director, officer: Chief Executive Officer	C/O TESARO, INC., 1000 WINTER STREET, SUITE 3300, WALTHAM MA 02451
James O Armitage	director	C/O TESARO, INC., 1000 WINTER ST., SUITE 3300, WALTHAM MA 02451
Timothy R Pearson	officer: Exec. VP, CFO	C/O TESARO, INC., 1000 WINTER STREET, SUITE 3300, WALTHAM MA 02451
Garry A Nicholson	director	C/O TESARO, INC., 1000 WINTER STREET, SUITE 3300, WALTHAM MA 02451
Grant C. Bogle	officer: Sr. VP, Chief Commercial Ofc	C/O TESARO, INC. 1000 WINTER STREET, SUITE 3300 WALTHAM MA 02451
Nea Partners 13, Limited Partnership	10 percent owner	1119 ST. PAUL STREET, BALTIMORE MD 21202
Nea 13 Gp, Ltd	10 percent owner	1119 ST. PAUL STREET, BALTIMORE MD 21202
New Enterprise Associates 13 Lp	10 percent owner	1119 ST PAUL STREET, BALTIMORE MD 21202
Collier Earl M Jr	director	C/O TESARO, INC., 1000 WINTER STREET, SUITE 3300, WALTHAM MA 02451
Beth C Seidenberg	director
Joseph L Farmer	officer: Sr VP, Gen Counsel & Secretary	C/O TESARO, INC. 1000 WINTER STREET, SUITE 3300 WALTHAM MA 02451
Patrick J Kerins	10 percent owner